SZSE:002793 (China)
Â
Class A
Â¥
3.94
(-0.51%)
Jun 18
Current and historical daily PE Ratio for Luoxin Pharmaceuticals Group Stock Co Ltd (
SZSE:002793
) from 2016 to Jun 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Luoxin Pharmaceuticals Group Stock stock (SZSE:002793) PE ratio as of Jun 18 2024 is 0.
More Details
Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) PE Ratio (TTM) Chart
Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1207
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Luoxin Pharmaceuticals Group Stock PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-19 | At Loss | 2024-04-11 | At Loss |
| 2024-06-18 | At Loss | 2024-04-10 | At Loss |
| 2024-06-17 | At Loss | 2024-04-09 | At Loss |
| 2024-06-14 | At Loss | 2024-04-08 | At Loss |
| 2024-06-13 | At Loss | 2024-04-03 | At Loss |
| 2024-06-12 | At Loss | 2024-04-02 | At Loss |
| 2024-06-11 | At Loss | 2024-04-01 | At Loss |
| 2024-06-07 | At Loss | 2024-03-29 | At Loss |
| 2024-06-06 | At Loss | 2024-03-28 | At Loss |
| 2024-06-05 | At Loss | 2024-03-27 | At Loss |
| 2024-06-04 | At Loss | 2024-03-26 | At Loss |
| 2024-06-03 | At Loss | 2024-03-25 | At Loss |
| 2024-05-31 | At Loss | 2024-03-22 | At Loss |
| 2024-05-30 | At Loss | 2024-03-21 | At Loss |
| 2024-05-29 | At Loss | 2024-03-20 | At Loss |
| 2024-05-28 | At Loss | 2024-03-19 | At Loss |
| 2024-05-27 | At Loss | 2024-03-18 | At Loss |
| 2024-05-24 | At Loss | 2024-03-15 | At Loss |
| 2024-05-23 | At Loss | 2024-03-14 | At Loss |
| 2024-05-22 | At Loss | 2024-03-13 | At Loss |
| 2024-05-21 | At Loss | 2024-03-12 | At Loss |
| 2024-05-20 | At Loss | 2024-03-11 | At Loss |
| 2024-05-17 | At Loss | 2024-03-08 | At Loss |
| 2024-05-16 | At Loss | 2024-03-07 | At Loss |
| 2024-05-15 | At Loss | 2024-03-06 | At Loss |
| 2024-05-14 | At Loss | 2024-03-05 | At Loss |
| 2024-05-13 | At Loss | 2024-03-04 | At Loss |
| 2024-05-10 | At Loss | 2024-03-01 | At Loss |
| 2024-05-09 | At Loss | 2024-02-29 | At Loss |
| 2024-05-08 | At Loss | 2024-02-28 | At Loss |
| 2024-05-07 | At Loss | 2024-02-27 | At Loss |
| 2024-05-06 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-23 | At Loss |
| 2024-04-29 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-08 | At Loss |
| 2024-04-22 | At Loss | 2024-02-07 | At Loss |
| 2024-04-19 | At Loss | 2024-02-06 | At Loss |
| 2024-04-18 | At Loss | 2024-02-05 | At Loss |
| 2024-04-17 | At Loss | 2024-02-02 | At Loss |
| 2024-04-16 | At Loss | 2024-02-01 | At Loss |
| 2024-04-15 | At Loss | 2024-01-31 | At Loss |
| 2024-04-12 | At Loss | 2024-01-30 | At Loss |
Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Luoxin Pharmaceuticals Group Stock Co Ltd
ISIN : CNE1000026S7
Share Class Description:
SZSE:002793: Class ACompare
Compare
Traded in other countries / regions
002793.China IPO Date
2016-04-15Description
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers